Biography

1. Research Interest

Main research direction: hepatobiliary surgery, liver transplantation. The area of accurate liver resection, allogeneic revascularization, hepatic cholangiocarcinoma radical resection, pancreatic cancer radical surgery, surgical treatment of portal hypertension and digestive tracthemorrhage, and the treatment of complex bile duct stones have been studied in depth. Besides, accumulating rich experience in the treatment of liver transplantation, salvage liver transplantation after liver resection and biliary complications after liver transplantation.

2. Educational Background

1990.9-1997.7 Graduated from the seven year program of clinical medicine at Nankai University medical school and received his master's degree.

1999.9-2002.6 Graduated from the Institute of Organ Transplantation,Tongji Medical College, Huazhong University of Science and Technology, with a Ph.D. in Surgery (General Surgery)

2010.7 -2011.6 The senior visiting scholar at University of Chicago's organ transplant center.

3.Work Experience

1997.8-1998.7 Department of General Surgery, Tianjin First Central Hospital, Resident Physician

1998.8-1999.8 Department of Transplant Surgery, Tianjin First Central Hospital, Resident Physician

1999.9-2006.10 Department of Transplant Surgery, Tianjin First Central Hospital,Attending Physician

2006.10-2011.10 Department of Transplantation Surgery, TianjinFirstCentral Hospital, Deputy Chief Physician

2011.11-present Department of Hepatobiliary Surgery, Tianjin First Central Hospital, Chief Physician

4. Awards

2015 years, the first level candidate of Tianjin's 131 innovative talents training project.

In 2010, Application and Promotion of Liver Transplantation for End-stage Hepatitis B won the second prize of Chinese MedicalScience and Technology Award.

In 2008, Prospective study on comprehensive prevention and treatment of biliary stricture after liver transplantation won the third prize of Tianjin Science and Technology Progress.

5. Social Service

2015.11.-2018.11 The first committee of general surgery branch of tianjin medical association,Vice-chairman

2015.11-2020.11 China academy of research hospitals hepatobiliary surgery professional committee ,Standing Committee Member

2017.11-2020.11China medical doctor association surgeons branch organ transplantation perioperative management committee,Vice-chairman

2015.6-2019.6 The first China laparoscopic liver resection development and promotion committee,Committee Member

2017.6-2021.6 China Healthcare international exchange promotion association liver cancer branch,Committee Member

2017.11-2021.6 International hepatobiliary and pancreatic association China branch hepatic hemangioma professional committee,Committee Member

2018.1-2023.1 The organ transplantation and metabolic diseases group of diabetes research committee of China research hospital association,Deputy Supervisor

2018.8-2023.8The first anticancer association of China for endoscopic and robotic surgeons association,Committee Member

Achievements

Peer-Reviewed Journal Papers

1.Yamin Zhang, Zirong Liu, Zilin Cui,et al.Interleukin-22 contributes to liver regeneration in mice with concanvaliin A-induced hepatitis after hepatectomy. World J Gastroenterol, 2016,14;22(6):22081-2091

2.Ya-min Zhang, Rui Shi, Jian-cun Hou,et al. Liver tumor boundaries identified intraoperatively using real-time indocyanine green fluorescence imaging. J Cancer Res Clin Oncol,2017,143(1):51-58

3.Diwu,Zhongyangshen,Yaminzhang,et al. Effect of liver transplantation in combined hepatocellular cholangiocellular carcinoma:a case series. BMC Cancer,2015(15):232

4.Rui Shi, Yamin Zhang, Yonglin Deng,et al. A retrospective stud of the occurrence of ischemic-type biliary lesions post liver transplantation. Life Sciences, 2016,59（5）:529-531.

5.Tian Qing,Zhang Yamin,Wang Guijie,et al.STAT6 silencing induce hepatocellular carcinoma-derived cell apoptosis and growth inhibitionby decreasing the RANKL expression. Biomedicine&Pharmacotherapy,2017,92:1-6.

6.Qing Tian,Guijie Wang,Yamin Zhang,er al.Endoscopic radiofrequency adlation combined with fully covered self-sxpandable metal stent for inoperable periampullary carcinoma in a liver transpant patient .Medicine,2017,96(5):e5790.

7.Lian-Jiang Wang,ZiRong Liu,Ya-Min Zhong,er al.Multiple primarycancers of liver and kidney complicated with tumor thrombosis in bile duct and portal vein: a case report. Int J Clin Exp Med,2017,10(10):14936-14939

8.Jian Wang, Jia-Sui Chai, Ya-Min Zhang,er al.Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaitingliver transplantation,Medicine,2018,97:26

Projects

1.2016.10-2019.10,“Application of regional liver reserve function evaluation technology in accurate hepatectomy”,Key Project of Tianjin Health Industry, Main Researcher

2.2014.04-2018.03,“IL-22 on the liver regeneration after the liver resection of the liver resection”,The Applied Foundation and Cutting-edge Technology Research Program in Tianjin, Main Researcher

3.2014.06-2016.05,“The ICG removal rate in the liver resectionevaluated the remaining liver function in the clinical study”,The Keysupport Program of The Tianjin Health Department, Main Researcher

4.2014.01-2017.12,“Study on the protective effect and mechanism of il-22 on small-volume transplanted liver after partial liver transplantation”,Project of National Science Foundation of China, The 3nd Researcher

5.2014.04-2017.03,“A study on the clinical strategy of maximizingthe use of organ donation for liver”,Tianjin Science and Technologyplan (key) Project, The 2nd Researcher

6.2012.06-2015.05,“Microcirculation disorder in DCD liver transplantation for the prevention of liver function injury”,Key Support Project of Tianjin Municipal Health Bureau, The 2nd Researcher

7.2013.6-2015.5,“RANKL pathway regulates the role of Th17 in liver transplantation rejection reaction”,Key Project of Science and Technology Fund of Tianjin Municipal Health Bureau, The 2nd Researcher